Background: Pre-exposure prophylaxis (PrEP) for prevention of HIV infection has demonstrated efficacy in randomized controlled trials and in demonstration projects. For PrEP implementation to result in significant reductions in HIV incidence for men who have sex with men in the United States, sufficient access to PrEP care and continued engagement outside of demonstration projects is required.
INTRODUCTION
Oral daily Pre-Exposure Prophylaxis (PrEP) with combination tenofovir/emtricitabine (TDF/FTC) is a proven strategy for HIV prevention in clinical trials, 1 and several recent studies and demonstration projects have exhibited success in engaging men who have sex with men with sexual risk for HIV infection in PrEP care. [1] [2] [3] [4] [5] [6] In many demonstration projects (open-label studies designed to evaluate the process of implementation), PrEP is provided free of charge in an easily accessible and supportive environment with comprehensive prevention services and in some studies, participants are reimbursed for their study activities. Participants who engage in demonstration projects develop PrEP knowledge and experience, but may have limitations in postproject access to medical care generally and PrEP care specifically. Comparison of PrEP recipients in a study setting with the same individuals in the period after the study intervention may reveal disparities in access to medical care and to PrEP that exist outside of a research setting, even for patients experienced in and knowledgeable about PrEP. Studies modeling PrEP access and availability and surveys of providers' and patients' anticipated behavior have attempted to estimate supply, demand, and access to PrEP. [7] [8] [9] [10] However, little is known about access to PrEP and continued engagement in HIV prevention services, including sexually transmitted infection (STI) testing and treatment and HIV testing for demonstration project participants after completion of these projects. To address these issues we evaluated facilitators and barriers in obtaining PrEP for a cohort of participants that had participated in the US PrEP Demonstration Project.
The US PrEP Demonstration Project was a 48-week open-label project enrolling 557 men who have sex with men (MSM) and transgender women at municipal sexually transmitted infection clinics in San Francisco and Miami and a community health center in Washington, DC All participants were offered daily oral PrEP. Uptake, engagement, and retention in the project during the 48 weeks of follow-up have been previously reported. 4, 11 In this follow-up assessment, we sought to understand the participant experience focusing on access to PrEP in the period after completion of the PrEP Demo Project.
METHODS
PrEP Demonstration Project participants at both the San Francisco and Miami sites received anticipatory counseling and guidance regarding PrEP access at the 36-and 48-week study visits. At these visits, study counselors discussed community resources for PrEP, including available providers and patient support programs and provided participants with a printed resource guide. Participants at both sites were queried during the informed consent process regarding willingness to be re-contacted after study completion and this information was re-confirmed at the last study visit. Four to 6 months after the final study visit, telephone contact was attempted with all participants from the Miami and San Francisco sites who indicated willingness to be re-contacted after main study completion (n = 349). Contact was attempted regardless of retention status in the main study. Three attempts were made to contact each participant. Verbal informed consent was obtained before telephone questionnaire administration. Questionnaires were administered in English or Spanish according to participant preference. The questionnaire consisted of 25 multiple-choice items with 5-point Likert scales for attitudinal questions and 2 open-ended questions regarding facilitators and barriers to PrEP care. The questionnaire required approximately 15-20 minutes to complete. Participants received a $20 gift card by mail after questionnaire completion. Topics included health access and insurance coverage, HIV and STI testing after study completion, PrEP access attempts, reported facilitators and barriers to obtaining PrEP, perception of PrEP efficacy and preferences for PrEP access locations, and reported sexual behavior changes since completing the project.
Responses were recorded directly in a secure web-based form (Qualtrics; Qualtrics Co., Provo, UT) by the interviewers. Responses to open-ended questions were transcribed by the interviewers. Data were downloaded to statistical software (SAS v 9.0; SAS Institute, Cary, NC) for further analysis.
Response rate was calculated based on the proportion of participants who completed the questionnaire of those for whom calls were attempted. A comparison of demographics and characteristics of those participants included in the follow-up survey with those who were not included, by site, was completed using t tests for continuous variables and x 2 tests for categorical variables. Racial and ethnic categories were combined for some analyses due to small number of follow-up survey respondents in each group.
Questionnaire results were presented descriptively. Results were compared by site and by demographic characteristics of the respondents. Bivariate comparisons were made using Fisher's Exact Test and with Mantel-Haenszel common odds ratio estimate calculated for comparison across groups. Denominators for some questions vary due to missing data.
We use random forests (RFs) to create a predictive model of who is likely to get PrEP after the study. RF is a type of ensemble learning method based on classification decision trees first described by Breiman. 12 These models repeatedly and randomly choose a subset of predictor variables and create a distinct classification tree at each step. The overall prediction is then averaged across the trees in the forest. These models are tuned to ensure that the estimated RF does not over fit the data; therefore, predictions from RFs are more likely to be replicated in new samples than modelbuilding based on logistic regression. Random forest does not provide standard errors of the individual predictors, rather it calculates the variable importance of each variable in the forest, by calculating how much the misclassification error increases if the particular variable is randomly permuted (essentially destroying any predictive power for that variable). We use the randomforestSRC package version 2.2.0. 13, 14 We present the variables sorted by their importance for predicting the likelihood of receiving PrEP after the Demonstration Project (Fig. 2) .
Study materials and procedures were approved by the Institutional Review Boards for the Florida Department of Health, University of Miami, and University of California, San Francisco.
RESULTS
All 157 participants enrolled at the Miami site and 192/ 300 (64.0%) at the San Francisco site of the Demo Project provided authorization for re-contact after the study; overall 173/457 (37.9%) of those enrolled at the 2 sites of the Demo Project completed the follow-up questionnaire. Response rates among eligible participants differed by site: San Francisco 74/ 192 (38.5%) and Miami 99/157 (63.1%; P , 0.001). Demographic comparisons of responders and nonresponders (including those who declined to give authorization for re-contact) are presented in Table 1 . Respondents were significantly more likely than nonrespondents to have been retained for all PrEP Demo study visits (P = 0.05), to be from the Miami site (P , 0.001) and to identify as white (P = 0.017 for heterogeneity by race), or Hispanic/Latino (P , 0.001). The racial and ethnic differences in response rate were not maintained when controlling for site (adjusted P = 0.104 for difference by race and P = 0.831 for Hispanic/Latino vs. non-Hispanic/Latino).
Among respondents, 159/173 (91.9%) indicated some level of interest in PrEP (Fig. 1) , including 127/173 (73.4%) who indicated that they were "very interested," 19/173 (11.0%) "somewhat interested," and 13/173 (7.5%) "a little interested" in taking PrEP after study completion, with no significant differences by site. At least one visit with a medical provider since completion of the Demo Project was reported by 119/173 (68.8%) of respondents. Reported providers visited included primary care provider (PCP) visits (81/173 respondents, 46.8%), sexually transmitted disease clinic visits (44/173, 25.4%), walk-in clinic visits (18/173, 10.4%), emergency room visits (11/173, 6.4%), and other provider visits, including sub-specialists, optometrists, and psychiatrists (13/173, 7.5%); many participants indicated visits to more than one type of provider. A discussion with a medical provider regarding PrEP in the period after the main study was reported by 88/173 (50.9%); significantly more respondents from San Francisco (58/74, 78.4%) indicated that they had discussed PrEP with a medical provider than from Miami (30/97, 30.9%; P , 0.0001). White non-Latino respondents were more likely to report discussing PrEP with a provider compared with respondents of other races and ethnicities; white non-Latino 48/63 (76.2%), all other race/ethnicity 40/ 108 (37.0%; P , 0.001, Fig. 1 ). This effect persisted when adjusted for study site. Most of those who had discussed PrEP with a medical provider felt that the provider was "Very Familiar" or "Somewhat Familiar" with PrEP (69/88, 77.3%) and felt that the provider was "Very Supportive" or "Somewhat Supportive" of PrEP use (72/88, 81.8%), with no significant differences by site.
Respondents who reported discussing PrEP with a medical provider but not receiving PrEP (n = 21), were more likely to be from Miami (P = 0.002), to be Hispanic/Latino (P = 0.001), to be uninsured (P , 0.001), and to be willing to pay less for PrEP (P = 0.001) compared with those who did receive PrEP after talking with a provider (n = 67); see (Table 2) . PCPs were the source of PrEP for 50/69 (72.5%); 25/69 (36.2%) received PrEP through PCPs at Kaiser Permanente (all from the San Francisco site). An additional 14/69 (20.3%) received PrEP through a specialist or other medical center where they did not receive primary care. One participant reported receiving PrEP through another study, and one reported using left over pills from the Demo Project. Three participants (4.3%) reported obtaining PrEP without a prescription on the internet (n = 1), from a friend (n = 1), or on the street (n = 1).
Seventy-seven of 173 respondents (44.5%) reported having a primary care provider (PCP) and 97/173 (56.1%) reported having health insurance at the time they entered the Demo Project. At the time of the survey, 107/171 (62.6%) reported having a PCP and 124/171 (72.5%) reported having health insurance (P , 0.01 for both PCP and insurance). Of respondents, 16.2% (n = 28/173) reported that wanting to continue PrEP motivated them to get health insurance coverage and/or a primary care provider. Wanting to continue PrEP was reported as a motivation to select a particular insurance plan by 8.1% (n = 14/173) of respondents.
Of those who were able to obtain PrEP, 85.5% (n = 59/ 69) indicated that they thought PrEP access was "Very Easy," or "Easy." PrEP medication was free for 50.7% (n = 35/69) of those who accessed it. Of the 49.3% (n = 33/67) who reported paying for PrEP, the mean amount paid out of pocket was $77/ month (SD $150.6; range $5-$600). Overall, 15% (n = 26/173) of respondents said that they attempted to access a pharmaceutical company patient assistance program/copay assistance program and of these 65.4% (n = 17/26) reported successfully receiving medication through a patient assistance program.
Few participants who had not taken PrEP since completion of the demonstration project reported that they had tried to obtain PrEP since completion of the project (19/102, 18.6%), with no significant differences by site (17.7% for Miami and 21.3% for San Francisco). Of the 19 who had attempted but failed to obtain PrEP after the project, 14 (73.7%) had attempted to obtain PrEP through a medical provider, 3 (15.8%) had attempted to obtain PrEP over the internet and 2 (10.9%) had attempted to obtain PrEP through another study. Among the 102 participants who did not take PrEP after completion of the Demo Project, the most commonly reported barrier was cost or lack of health insurance (n = 54) ( Table 3) .
Ranking of Predictive Factors: In random forest analysis of factors associated with obtaining PrEP, we incorporated all of the factors in Table 2 and added in the participant's ranking of whether the provider had been familiar with PrEP and whether he/she had been supportive of PrEP. These additional 2 questions were only answered if the participant reported talking to a provider about PrEP after the Demonstration project, and were coded as a separate "missing" category in the likert-rating if they had not talked to a provider. Supportiveness of the provider was the most predictive factor, closely followed by the provider's familiarity with PrEP and having discussed PrEP with a medical provider (Fig. 2) . Having a primary care provider and expressing stronger interest in PrEP continuation were also modeled to predict obtaining PrEP. The model predicted moderate impact of HIV testing frequency, willingness to pay for PrEP, having health insurance, site, and race. The supplemental figure, Supplemental Digital Content, http://links.lww.com/QAI/A948, examines the partial dependency plots associated with the top 3 variables. Discussing PrEP with a medical provider raises the probability of receipt from essentially 0 to around 90% (controlling for other variables in the model). Having a provider who is unsupportive of PrEP does lower the probability of PrEP receipt relative to having a very supportive or supportive provider. The plot on familiarity with PrEP shows little difference in probability of PrEP receipt across levels of familiarity. The real difference driving this variable's inclusion in the list is the missing data category. Thus this variable is acting as a proxy for asking a provider about PrEP.
Five of 173 participants (2.9%) reported receiving a course of nonoccupational postexposure prophylaxis (nPEP) in the time between completion of the Demo Project and the follow-up survey. Of these participants, one also reported receiving PrEP in the follow-up period. No respondents reported more than one course of nPEP since study completion. Diagnosis and/or treatment for a new sexually transmitted infection (STI) since study completion had been reported by 22.5% of respondents (n = 38/169).
Most participants (133/173, 76.9%) reported at least one HIV test since the last study visit (mean number of tests = 1.9; SD = 2.0; range 0-12). Two respondents reported a positive test for HIV since project completion. Both were from the Miami site and had engaged in HIV care with initiation of antiretroviral medication at the time of the questionnaire. One of the participants had completed all study visits and the other had been lost to follow-up before the 12-week study visit but returned for the final termination study visit. Both participants were tested with a negative result using fourth generation HIV antigen/antibody testing at the final study termination visit; the positive tests were 3 and 4 months after the final study termination visit. Neither participant reported medical insurance or a primary care provider at the time of study termination and neither reported attempting to access PrEP since study completion. One reported taking a course of nPEP between study completion and the positive test.
DISCUSSION
In our survey of participants after the conclusion of the PrEP Demo Project, we found that PrEP interest remained high among a large majority of respondents and did not significantly differ by geographic location, age, race, ethnicity, income, or insurance status. PrEP access after study completion, however, was variable. Many participants, particularly white participants and those from the San Francisco site, were able to successfully transition into PrEP care outside of the study, although one-third did encounter a gap between study completion and initiation of PrEP from another source. For the majority, PrEP was obtained through PCPs, and those who successfully obtained PrEP generally felt that the process was "easy" or "very easy," suggesting that once a PCP was accessed and a plan for PrEP was initiated, significant barriers were not commonly encountered.
A significant proportion of respondents, however, were unable to successfully access PrEP from community sources. These respondents were more frequently from the Miami site, and more likely to be non-white and/or Latino (Fig. 1) . Disparities in access are apparent in the necessary step of discussing PrEP with a medical provider. In random forest analysis to determine variables independently predictive of obtaining PrEP, having a discussion with a medical provider about PrEP was a highly weighted variable, reinforcing that accessing a PrEP provider is a rate-limiting step for many individuals seeking PrEP and that in most cases PrEP is successfully obtained once a provider is accessed. Perceived provider support for PrEP had an influence in the RF model, suggesting that programs to enhance both the availability and preparation of providers to facilitate informed and supportive care of PrEP clients may be useful. However, characteristics of the relatively small group of respondents who discussed PrEP with a provider but did not receive PrEP followed a similar pattern to those who did not receive PrEP overall, suggesting persistent structural barriers related to site, insurance, and socioeconomic status in obtaining medication.
Willingness to pay more for PrEP was a moderate predictor of receipt of PrEP in the RF analysis and may reflect a combination of perceived value and financial resources. Cost and lack of health insurance were the greatest perceived barriers to PrEP. Miami PrEP Demo participants were more likely to be uninsured compared with San Francisco participants (data not shown), in part due to the lack of state-wide Medicaid expansion in Florida. Miami has health insurance coverage rates among the lowest of all US large metropolitan areas as well as lower mean income and higher rates of undocumented immigrants than San Francisco. [15] [16] [17] These structural constraints are compounded by documented disparities in employer-sponsored insurance and indices of health access among MSM, particularly MSM of color and those in the Southern United States 18, 19 leading to reduced healthcare access and likelihood of PrEP continuation. Importantly, desire for PrEP influenced choice of insurance and engagement in care with a PCP for participants at both sites, suggesting that PrEP can be a primary consideration in healthcare decisions and may motivate engagement in health care if these structural barriers can be adequately addressed.
Despite the barriers to PrEP access observed in our study, many more participants reported a medical provider visit than continued on PrEP; these visits were most frequently with PCPs or sexually transmitted disease clinics indicating potential missed opportunities for PrEP engagement. 20 Venues other than primary care clinics that have been proposed or explored for PrEP implementation include municipal STI clinics, community based organizations with a focus on sexual or reproductive health, and walk-in clinics. [20] [21] [22] Offering PrEP in a variety of locations may increase availability for those without established primary care or a reluctance to discuss PrEP or sexual health with their PCPs, a well-documented barrier to PrEP. [23] [24] [25] Relatedly, one of the 2 reported HIV seroconversions occurred after a course of nPEP after study completion, reinforcing the need to actively engage those completing nPEP courses in prevention services and transition to PrEP whenever appropriate. 20 Cost was by far the greatest perceived barrier to PrEP access, consistent with other studies evaluating barriers to PrEP among MSM in the United States; PrEP costs (medication, laboratory testing and provider visits) can be challenging without insurance coverage or robust safety net systems. 8, 26, 27 For just about half of the participants who were able to access PrEP, no out of pocket expense was incurred for the medication itself. However, many participants citing cost and lack of insurance as a major deterrent to continue PrEP utilization had not actually attempted to access PrEP after study completion, possibly indicating perceived futility regarding ability to access PrEP at reasonable cost. Governmental programs that cover the cost of PrEP medication, 28 cost of associated provider visits and laboratory testing, 29 or that support provision of PrEP in municipal STI clinics 30 may provide increased access to PrEP for uninsured and underinsured individuals at risk for HIV-infection. Counselors and patient navigators knowledgeable regarding community resources for PrEP access may also facilitate more equitable PrEP implementation and ensure that individuals are aware of all programs available that can defray the cost of PrEP care.
Estimates of PrEP coverage necessary to provide substantial reductions in HIV infections among HIV-negative MSM vary but assume a minimum of 20%-40% PrEP uptake to realize decreases in HIV incidence. [31] [32] [33] [34] [35] [36] [37] [38] Engaging a large proportion of eligible individuals in PrEP care requires individual knowledge and acceptance of PrEP as a riskreduction strategy, availability of providers who are knowledgeable and willing to prescribe PrEP, mechanism for payment for the medication, office visits, and testing, and ability to adhere to the medication schedule. 8, 37, [39] [40] [41] In a study modeling theoretical PrEP access in Atlanta, a metropolitan area with large numbers of low income and uninsured or underinsured individuals, fewer than 20% of those eligible for PrEP were predicted to successfully access the intervention, with lower rates among black MSM largely due to decreased coverage with medical insurance and decreased access to medical care 8 ; In our cohort, continuation of PrEP for those without insurance at the time they left the project was 18%, and was 20.6% for non-white or Latino participants. In contrast to the modeling assumptions from the Atlanta study, all individuals in our study had previously met PrEP eligibility criteria and had previously decided to use PrEP when it was provided in an open-label study context, suggesting that the overall PrEP continuation in our realworld participants was significantly less than that would have been predicted. Disparities in PrEP access among non-white participants are particularly concerning as MSM of color are disproportionately affected by HIV; in 2014, newly diagnosed HIV infections among black or Latino MSM were more than twice those of white MSM. 42 The geographic disparities evident in PrEP continuation are also alarming as more than 50% of new HIV infections now occur in the Southern United States, 43 and Miami is the city with the highest rates of new HIV infections in the United States., 42 reinforcing the need for provision of resources for access to effective prevention strategies across US regions.
Our observation of decreased PrEP access among younger participants, those without health insurance, with lower income, and with lower educational attainment is concerning as HIV disproportionately impacts individuals with these characteristics. 44 Programs that facilitate access to PrEP providers and minimize out-of-pocket expenses related to PrEP access as well as reduction in structural and logistical barriers to obtaining PrEP may assist with correcting these disparities. Data from projects focusing on PrEP and HIV treatment engagement among young adults suggest that specific interventions such as closer follow-up, electronic reminders, and more flexible clinic schedules may facilitate greater persistence in care. [45] [46] [47] To allow PrEP to achieve a substantial impact on incident HIV infections, additional work and innovation is needed to optimize PrEP use in highly affected groups including youth and those with low socioeconomic status.
Our study has several limitations. The follow-up study was optional and only 37.8% of PrEP Demo participants elected to complete the survey. However, the characteristics of the sample who responded were similar to those of the sample who did not respond. Furthermore, participants from the Miami site had a higher response rate compared with participants from San Francisco, raising the possibility of differential selection bias at the 2 sites. The small number of black MSM who completed the follow-up survey does not allow specific analysis of PrEP access in this important subgroup. Follow-up survey outcomes such as provider visits, PrEP access, and STI diagnoses are self-reported and therefore reporting bias is also possible. Despite these limitations, participants in a PrEP Demonstration Project are individuals who have expressed an interest in starting PrEP as an HIV prevention strategy and the subsequent experiences of this group are informative regarding patterns of engagement with medical care outside of a study setting and barriers to successful PrEP continuation.
In our study of individuals previously electing to take PrEP, the most significant bottleneck to continued PrEP engagement occurred with access to a medical provider, and seemed to be largely driven by lack of insurance and established primary care. Lack of Medicaid expansion and safety-net services exacerbate geographic and socioeconomic disparities in access to PrEP. Addressing these barriers will be required to achieve levels of PrEP engagement sufficient for a meaningful public health impact and to ensure distribution of PrEP access that includes communities in the United States most at risk for HIV infection.
